Abstract:Objective To evaluate the effects of extracts of Semen Coicis (ESC) on a BALB/c mouse model of atopic dermatitis (AD),and to explore its potential mechanism.Methods Forty specific pathogen-free (SPF) female BABL/c mice were randomly divided into blank group (8 mice,receiving no treatment) and AD model group (32 mice).The mice in the model group were topically treated with 2,4-dinitrochlorobenzene (DNCB) in acetone/olive oil to establish the mouse model of AD.After modeling,8 mice in the blank group and 8 in the model group were sacrificed immediately.The other 24 mice in the model group were randomly and equally divided into 3 groups:model control group receiving no treatment,ESC group and ESC vehicle group topically treated with ESC and ESC vehicle respectively once every day on the back and aural region of the mice for 28 consecutive days.Changes in skin lesions were observed by naked eyes every day.A thickness tester was used to measure the thickness of skin lesions on the left ear before modeling,at completion of modeling and 12 hours after the final treatment.At 12 hours after the final treatment,the mice in the above 3 groups were sacrificed,and the eyeballs were removed for collecting blood.Then,the sera were isolated,and skin tissue specimens were obtained from the skin lesions on the back.These tissue sections were subjected to hematoxylin and eosin (HE) staining and toluidine blue staining for observing the infiltration of inflammatory cells in skin lesions.An immunohistochemical study was performed to determine the expression of aquaporin 3 (AQP3),Toll-like receptor 2 (TLR2) and TLR4,and enzyme-linked immunosorbent assay (ELISA) to detect the serum levels of IgE,interleukin-4 (IL-4) and interferon-/ (IFN-γ).Results After 28-day treatment,skin lesions were improved in the ESC group.Compared with the model control group,the ESC group showed a significantly lower clinical symptom score (1.50 ± 0.58 vs.2.50 ± 0.58,P ＜ 0.05),decreased lesional thickness on the left ear ([0.31 ± 0.01] mm vs.[0.33 ± 0.01] mm,P ＜ 0.05),and lower number of infiltrating mast cells per high-power field (15.18 ± 1.64 vs.28.94 ± 1.28,P ＜ 0.05).Immunohistochemical findings indicated that the ESC group showed significantly lower expression of AQP3,TLR2 and TLR4 compared with the model control group,and decreased AQP3 expression in the spinous layer.Compared with the model control group,the ESC group showed significantly lower total serum IgE and IL-4 levels,but higher IFN-γ levels (all P ＜ 0.05).Conclusion Topical ESC is effective for the treatment of skin lesions in mouse models of AD,likely by regulating serum levels of IgE,IL-4 and IFN-γ and affecting the expression of AQP3,TLR2 and TLR4.

Epicutaneous Sensitization with Ovalbumin, Staphylococcal Enterotoxin B and Vitamin D Analogue Induces Atopic Dermatitis in Mice.

Atopic Dermatitis Enhanced Ovalbumin-Induced Airway Inflammation in Mice

Identification of Candidate Genes in Atopic Dermatitis Based on Bioinformatic Methods

Topical Emollient Prevents the Development of Atopic Dermatitis and Atopic March in Mice.

Comprehensive analysis of phenotypes and transcriptome characteristics reveal the best atopic dermatitis mouse model induced by MC903

Role of mast cells in Staphylococcus aureus enterotoxin B-induced atopic dermatitis-like skin inflammation in mice

Pharmacological basis of the putative therapeutic effect of Topical Vitamin D3 on the experimental model of atopic dermatitis in mice

Gene expression analysis of atopic dermatitis-like skin lesions induced in NC/Nga mice by mite antigen stimulation under specific pathogen-free conditions

Effects of extracts of Semen Coicis on a BALB/c mouse model of atopic dermatitis and its mechanism

Epicutaneous Antigen Challenge of Orally Sensitized Mice Elicits Allergic Dermatitis by Redirecting Α4β7 Gut Homing T Cells to the Skin (79.7)

[Development of Allergic Airway Disease Model in Mice].

Prevention of Atopic Dermatitis in Mice by <i>Lactobacillus Reuteri</i> Fn041 Through Induction of Regulatory T Cells and Modulation of the Gut Microbiota

Animal models of atopic dermatitis.

A Mouse Model of Atopic March Induced by Epicutaneous Immunization with House Dust Mite Allergen: a Preliminary Study

Exogenous Drugs-Induced Mouse Models of Atopic Dermatitis

Adipose-derived stem cells ameliorate atopic dermatitis by suppressing the IL-17 expression of Th17 cells in an ovalbumin-induced mouse model

Fecal microbiota transplantation as a new way for OVA-induced atopic dermatitis of juvenile mice

The Natural Course of Atopic Dermatitis and the Association with Asthma

Oral Administration of Apple Pectin Solution Improves Atopic Dermatitis in a Mouse Model

Anti-Inflammatory Effect of Qingpeng Ointment in Atopic Dermatitis-Like Murine Model

Establishment and Characterization of Mild Atopic Dermatitis in the DNCB-Induced Mouse Model